NEW YORK, NY--(Marketwire - Oct 19, 2011) - IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult stem cells, announced today it has appointed pediatrician, Dr. Sigmund Norr to its Board of Advisors. Dr. Norr, of the Cleveland Clinic, joins ten other prominent doctors on the Company's Board of Advisors.